(1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate hydrobromide (1:1)(CAS: 6533-68-2)

This compound falls under various regulatory guidelines, including the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for hazard communication. In Europe, it is subject to the REACH regulations, requiring detailed information on the substance and its safe use. The FDA and EPA may also have specific requirements for its handling, storage, and disposal due to its chemical composition and potential health effects.

Alternatives to this compound in synthesis include other hydrobromide salts with similar structures, such as (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2R)-3-hydroxy-2-phenylpropanoate hydrobromide. Isomers and analogs like (1R,2R,4R,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate can also be considered depending on the specific application and desired properties.

The market for this compound shows increasing interest in its biological activities and potential pharmaceutical applications. Research trends indicate a focus on its use in drug discovery and development, particularly in areas like anti-inflammatory and anti-cancer treatments. Price trends reflect the growing demand in these sectors, with potential for further market expansion as more applications are discovered.

Waste containing this compound should be handled according to local and national regulations, particularly those related to hazardous waste management. It is recommended to collect the waste in appropriate containers, label them clearly, and dispose of them through professional waste disposal services. Environmental protection measures should be taken to prevent any potential impact on the environment, including proper incineration or other safe disposal methods as per regulatory guidelines.